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Abstract Herbimycin A, a potent tyrosine kinase inhibitor, sup-
pressed nitric oxide synthase (NOS) induced by lipopolysac-
charide (LPS) and interferon-y (IFN-y) in C6 glial cells. LPS 
activated NF -KB, and this effect was inhibited by pretreatment 
with herbimycin A. In addition, IFN-y activated the tyrosine 
protein kinase, JAK2, and tyrosine-phosphorylation by itself was 
also inhibited by herbimycin A. These results suggest that her-
bimycin A suppresses iN OS induction by inhibition of both 
NF-KB activation caused by LPS, and tyrosine-phosphorylation 
of JAK2 caused by IFN-y in C6 glioma cells. 
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1. Introduction 
Recent reports have shown that nitric oxide (NO), a short-
lived gaseous molecule, is a potent biological mediator in the 
vascular. immune, and nervous systems [1,2]. In particular, NO 
is believed to be involved in neurotOXicity after various neu-
ronal stresses and in synaptic plasticity in the cerebellum and 
the hippocampus in the central nervous system (CNS) [3]. In 
the brain, a constitutively expressed calcium-dependent NO 
synthase (cNOS) is expressed in specific neuronal populations, 
where it can act as mentioned above. On the other hand, an-
other type of NOS, inducible NOS (iNOS), is expressed m brain 
glial cells when induced by treatment with bactenal endotoxin 
(lipopolysacchande. LPS) and/or cytokines [4-6]. 
However, the signal transduction system responsible for in-
duction of iNOS is poorly understood. In the mouse macro-
phage cell line RAW 264.7, LPS activates the nuclear transcrip-
tion factor NF-KB [7]. Moreover, same group also reported that 
NF-KB was necessary for LPS inducibility of the iNOS pro-
moter in those cells [8]. In rat primary cultured astrocytes and 
rat C6-N glioma cells. genistem suppressed INOS induction 
stimulated by LPS plus cytokines [9]. High concentrations of 
genistein (> 15 ,LIM), however, are known to inhibit not only 
tyrosine kinases but also other types of protein kinases such as 
protein kinase C (serine/threonine kinase) [10]. Thus, no target 
protein kinases of genistein have been identified in detail. To 
clarify the mechanism of iN OS expression stimulated by LPS 
plus IFN-y in glial cells. we investigated the effects ofherbimy-
cin A. a potent selective tyrosine kinase inhibitor [11]. on LPS 
plus IFN-y-induced iNOS expw,sion in an astrocyte cell line, 
rat C6 glioma cells. Our results indicate that inhibitory effects 
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ofherbimycm A on iNOS expression are due to the suppression 
of both NF-KB activation and tyrosine-phosphorylation of 
JAK2. 
2. Materials and methods 
2 I. Materials 
Rat C6 glIoma cells were obtamed from the AmerIcan Type Culture 
CollectIOn (USA). The plasmid carrying cDNA sequence for INOS 
(pTZ 18U) was a kmd gift from Dr. H Esuml [12]. Oligo(dT)-latex was 
obtained from Takara Biomedicals (Japan) Protem G-Sepharose beads 
and poly(dI-dC) were obtamed from Pharmacla BIOtech (USA) Antl-
phosphotyrosme antibody (4GIO) and antl-JAK2 antiserum were ob-
tamed from Upstate BIOtechnology Incorporated (USA). Antl-iNOS 
antibody was obtained from TransductIOn laboratones (UK) NF-KB 
consensus olIgonucleotides (5'-AGT TGA GGG GAC TTT CCC AGG 
C-3'), antl-NF-KB (p50) antibody and (p65) antibody were obtamed 
from Santa Cruz BIOtechnology Inc. (USA). lPS, IFN-y, and herblmy-
cm A were obtamed from Sigma (USA)' Gibco BRl (USA), and Wako 
Pure Chemical Industnes ltd. (Japan), respectively. 
22 Cell cull lire 
Rat C6 glIoma cells were mamtamed m F-IO medIUm supplemented 
With 15% horse serum, 2.5% fetal calf serum, 50 ,ug/ml penIcillin and 
100,ug/ml streptomycm m a humidified incubator contammg 5% CO,. 
2 3 We.l't('rn hfot anal)'SlI 
Cells (6 x 10') were ~ashed With 3 ml of ice-cold phosphate-buffered 
saline (PBS), harvested and sOnIcated for 5 s. The Iysates were centn-
fuged at 15,000 rpm for 20 min at 4°C and supernatants were bOiled 
With SDS sample buffer for 5 min. Samples were stored at -70°C until 
use 
Samples were subjected to 7.5% SDS-PAGE followed by transfer on 
mtrocellulose filters at 100 V for I h at 4°e. Filters were then blocked 
With TBST (10 mM Tns-HCI, pH 7.5,100 mM NaCl, 01% Tween 20) 
contammg 1% bovme ;,erUll! albumm (BSA) for I hand mcubated With 
the first antibody m TBST for I h at room temperature. After three 
wa;,hes with TBST, filters were incubated WIth the secondary antibody 
(anti-mouse IgG-horseradlsh peroXidase conjugate, 1:2000 dilutIOn m 
TBST) for 45 mm. After three washes with TBST, antIbody-reactive 
bands were revealed by chemilummescent detectIon (ECl Western 
detectIOn kit; Amersham InternatIOnal). 
24 RNA isolatIOn and Northem bioI £lnall'SI.1 
Total cellular RNA was prepared from i.2 x 10' cells usmg the gua-
mdmlUll!-ceslUm chlonde method as described previously [13]. 
Poly(At RNA was Isolated by the ohgo(dTJ-latex method [14]. Five 
,ug of poly(AJ' RNA was denatured by heating at 55°C for 15 mm In 
2.2 M formaldehyde, 50% (v/v) formamide, electrophoresed m 1% 
agarose gels con tamIng 22M formaldehyde and then transferred on 
mtrocellurose filters by capillary actIOn usmg 20 x SSC (I x SSC IS 
O.Dl5 M sodIUm citrate buffer, pH 7.0, containing 0.15 M NaCl) The 
filters were prehybridized for 5 h at 40°C m a solutIOn contammg 50% 
formamlde, 50 mM NaP" 5 x SSe. I x Denhardfs solutIOn and 60 
,ug/ml salmon ,perm DNA, and then mcubated for 16 h at 42°C In the 
same solutIOn (except for 5 ,ug/ml salmon sperm DNA) With "P-labeled 
DNA probe speCific for INOS (a 700 hp DNA fragment mcluding the 
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5' portion of the cloned rat liver mducible-type NO synthase cONA 
[12]) labeled with [a_32P]dCTP using a random primer ONA labelmg 
kit (Takara, Japan). Following washing of the filters twice at 68°C in 
2 x SSC, 0.1 % SOS for 30 min and twice at 68°C in I x SSe, 0.05% SOS 
for 30 min, autoradIOgraphy was performed by exposure for 16 h to 
Imaging plates and visualized on a FVJIX BAStatlOn (Fuji Photo Film 
Co" Japan). 
2.5. Electrophoretic mobility shift assays (EMSA) and antibody 
Inhibition 
Nuclear extracts were prepared usmg a slight modIfication of the 
method described previously [IS]. Briefly, 3 x 106 cells were harvested, 
washed once with 2 ml of ice-cold PBS and resuspended in 400 ml of 
buffer A consIsting of 10 mM 2-[4-(2-hydroxyethyl)-l-piperazinyl]-
ethanesulfonic acid (HEPES, pH 7.9), 10 mM KCI, 0.1 mM EOTA. 
0.1 mM EGTA, I mM dlthiothreitol (OTT), 0.5 mM phenylmethyl-
sulphonyl fluoride (PMSF), and 20 V/ml aprotmin. After incubatIOn 
for IS mm on ice, Nonidet PAO was added to a final concentration of 
0.6% and vigorously vortex mixed for 10 s. Nuclei were precipitated and 
resuspended in 50,u1 of buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCI, 
I mM EOTA. I mM EGTA, I mM OTT, I mM PMSF, and 20 V/ml 
aprotinm) and vigorously vortex mixed for 15 mm at 4°C. Lysates were 
centrifuged at 15,000 rpm for 20 min at 4°C and supernatants contain-
ing the nuclear proteins were transferred mto new vials. The protein 
concentrations of extracts were measured usmg a BIO-Rad protein 
assay kit. 
Electrophoretic mobility shift assays [16] were performed by incubat-
ing 7.5,ug of nuclear extracts with 2,ug ofpoly(dI-dC) m binding buffer 
(10 mM Tris-HCI, pH 7.5,50 mM NaC!, 1 mM EOTA, I mM OTT, 
I mglml BSA, 0.05% NP-40, 5% glycerol) (20,u1 final volume) for 30 
mm at 4°C. Then, end-labeled double-stranded oligonucleotide probe 
(50,000 cpm/0.3 ng) was added and the reaction mIxture was incubated 
for IS mm at room temperature. For supershift assay with specific 
antibodIes against NF-KB, nuclear extracts were preincubated with I 
,ug of each antibody for 2 h at 4°C before addition of end-labeled 
double-stranded olIgonucleotIde probe was added [17]. The samples 
were separated by 5% natIve polyacrylamide gel electrophoresis in low 
ionic strength buffer (0.25 x Tris-borate-EOTA). 
2.6. Immunopreciplfation 
Cells (3 x 106) were scraped into 500,u1 of lysis buffer (50 mM TrIs-
HCI, pH 7.4, 137 mM NaCI, 2 mM EGTA, I mM sodiUm orthovana-
date, I mM PMSF, 0.5% Triton X-IOO and 20 V/ml aprotinm) and 
broken by passage through a 21-gauge needle. The Iysates were soni-
cated for 5 s and centrifuged at 15,000 rpm for 20 mm at 4°C. The 
supernatants were precleaned with 50 ml of protein G-Sepharose beads 
(50% slurry) for I h at 4°C. After removal of nonspeCIfic immune 
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complex, 4,u1 of antI-JAK2 antIserum was added, and the mixture was 
mcubated for 4 h at 4°C. Immune complexes were precipitated WIth 30 
,Ill of protein G-Sepharose beads (50% slurry) and washed five times 
with I ml of ice-cold lysis buffer. Bound proteins were eluted 1Jy heatmg 
the samples with 60 ml of 2 x SOS sample buffer for 5 min at 95°C. 
Samples were stored at -70°C until use. 
3. Results 
3.1. Herbimycin A inhibits the LPS- plus IFN-y-stimulated 
lNOS induction in C6 glioma cells 
We observed that accumulation of N02-, a breakdown prod-
uct of NO produced by LPS- plus IFN-y-induced iNOS, was 
considerably decreased by pretreatment with herbimycin A, a 
potent protem tyrosine kinase inhibitor [II], in C6 glioma cells. 
To examine whether herbimycin A inhibits the LPS- plus 
IFN-y-stimulated iN OS induction at transcription and transla-
tion stages, cytosolic fraction and poly(At RNA were pre-
pared from C6 glioma cells pretreated with herbimycin A prior 
to LPS- plus IFN-y stimulation and subjected to Western blot 
and Northern blot analysis, respectively. Herbimycin A sup-
pressed the induction of both 130 kDa iNOS protein (Fig. I A) 
and mRNA (Fig. I B) in a concentration-dependent manner 
with a half -maximal effect at approximately 0.3 .ug/ml. 
3.2. Herbimycin A inhibits LPS-induced NF-KB activation in C6 
glioma cells 
CDI4, the only molecule that has been demonstrated defini-
tively to be involved in LPS-initiated cellular activation, is a 53 
kDa glycosylphosphatidylinositol-Iinked antigen present on 
macrophages and monocytes [18] which mediates LPS stimula-
tion of the translocation of the transcription factor NF-KB into 
the nucleus. To investigate the signal transduction system in-
ducing NOS, we next studied whether LPS also mediates 
NF-KB activation in C6 glioma cells as found in macrophages 
and neutrophils. C6 glioma cells were treated with 10 mg/ml 
LPS for increasing periods of time. Nuclear extracts were pre-
pared as described in section 2 and samples were subjected to 
EMSA using a DNA probe containing the NF-KB-bmding ele-
ment. NF-KB was detected in C6 glioma cell nuclear extracts 
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FIg. 1. InhibItIon of LPS- plus IFN-y-stImulated iNOS induction by herblmycin A. (A) Effect of herblmycin A on iN OS protem levels. 6 x 105 cells 
were pretreated for 12 h with herbimycin A at the indicated concentrations followed by stimulatIOn with 10,uglml LPS plus 250 V/ml IFN-y for 
36 h (lane 2-8). iNOS protein levels were then determined by Western blot analYSIS as described in section 2. (B) Effect of herbimycin A on iNOS 
mRNA levels. mRNA was isolated from 1.2 x 107 cells pretreated for 12 h with herbimycm A at the indicated concentratIOns followed by stimulatIOn 
WIth 10 ,uglml LPS plus 250 V/ml IFN-y for 24 h (lane 2-7) and determined by Northern blot analYSIS as deSCrIbed m section 2. 
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FIg 2 (A) Identification of nuclear NF-KB complexes. 3 x 10" cells were treated wIth 10,ug/ml LPS for I h (lanes 2-6) before preparIng nuclear extracts 
for analysis by EMSA. Nuclear extracts were incubated In the absence (lane I and 2) or presence (lanes 5 and 6) of I mg of specIfic antibodIes to 
each NF-KB component and a molar excess of unlabeled oligonucleotIde probe (70-fold with probe, lane 3). CK (lane 4) represents control normal 
rabbit serum. (B) InhIbItIOn of LPS-induced NF-KB actIvatIOn by herbImycin A. C6 cells were pretreated for 12 h with herbimycIn A at the indicated 
concentratIOns followed by InCUbatIOn with 10,ug/ml LPS for I h. Then, nuclear extracts were prepared and analyzed by EMSA 
within 15 min reaching maximal levels within 60 min following 
exposure to LPS (data not shown). Peak activation of C6 
glioma cells resulted in an approximately 20-fold increase in 
nuclear NF-KB levels as determined by scanning densitometry 
(lanes I and 2, Fig. 2A). In addition, LPS-stimulated 
NF-KB complexes dramatically disappeared when the nuclear 
extract was co-incubated with non-radio labeled DNA (lanes 2 
and 3). The identity of the complexes was determined using 
anti-NF-KB p50 and p65 antibodies. Control rabbit IgG 
had no effect on LPS- stimulated NF-KB complexes in EMSA 
(lane 4). However, anti- p50 and p65 antibodies completely 
eliminated the complexes generated with C6 glioma nuclear 
extracts (lanes 5 and 6). 
Moreover. to examine whether herbimycin A inhibits the 
LPS-induced NF-KB activation, nuclear extracts were prepared 
from C6 cells pretreated wIth herblmycin A prior to LPS stim-
ulation and subjected to EMSA. As shown in Fig. 2B, herbimy-
cin A inhibited LPS-activated NF-KB localization in nuclei in 
a concentration-dependent manner with a half-maximal effect 
at approximately 0.5 Jlg/ml. 
33 Herhlmycm A inhibits the IFN-y-stunulated tyrosine-
pho.lphorylation oj JAK2 in C6 glioma cells 
Another stimulator, IFN-y, binds to its own cell-surface re-
ceptors and then causes actIvation of the associated protein 
kinases such as JAKs [19]. Firstly, to examine whether IFN-y 
phosphorylates tyrosine residues of JAKs in C6 glioma cells, 
we performed immunoprecipitation using antibodies against 
JAKL JAK2, and Tyk2. Subsequently, the immune complexes 
were subjected to Western blot analysis using an anti-
phosphotyrosine antibody. In the quiescent state, tyrosine-
phosphorylation of JAK I, JAK2, or Tyk2 were not detectable. 
IFN-y specifically stimulated tyrosine-phosphorylation of 
JAK2, and slightly stimulated tyrosine-phosphorylation of 
JAKL but not of Tyk2 (data not shown). Next, to examine 
whether herbimycin A 1l1hibits IFN-y-stimulated tyrosine-
phosphorylation of JAK2, we pretreated C6 glioma cells with 
herbimycin A prior to IFN-y stimulation and performed im-
munopreeipitation using an antibody against JAK2. The tyro-
s1l1e-phosphorylation of JAK2 was suppressed by pretreatment 
with 0.5 Jlg/ml herbimyein A (Fig. 3). 
4. Discussion 
4.1. LPS stimulates NF-KB activation via tyrosine kinase 
It has been shown that LPS binds to the cell-surface receptor 
CDI4. Stefanova et al. [20] reported that tyrosine protein ki-
nase p53/561yn could be co-immunoprecipitated with CDl4 
using antl-CDl4 antibodies in human monocytes. On the other 
hand, Delude et al. [21] reported that CDl4-mediated translo-
cation of NF-KB stimulated by LPS did not require tyrosine 
kinase activity in CHO-K I cells transfected with human CD 14. 
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Fig. 3. Inhibition ofIFN-y-induced tyrosine-phosphorylation of JAK2 
by herbimycin A. 3 x 106 cells were pretreated for 12 h with herbimycin 
A at the indicated concentratIOns followed by mcubation with 250 Ulml 
IFN-y for 5 min (lanes 2-4). Whole cell Iysates Immunoprecipitated 
with anti- JAK2 antiserum were blotted with anti-phosphotyrosine 
antibody. 
Thus, the signal transduction system of LPS is still unclear 
Anderson et al. [22] reported that NF-KB activation was regu-
lated by both tyrosine kinases and phosphatase in human T-cell 
lines. The tyrosine kinases involved in intracellular signaling 
pathways following LPS stimulation are not always located in 
membranes. The present results indicate that even a lower con-
centration ofherbimycin A can inhibit NF-KB activation stim-
ulated by LPS in C6 glioma cells (Fig. 2B). This inhibition may 
be due to inhibition of: (1 ) receptor-associated tyrosine kinases 
such as lyn; or (2) unidentified tyrosine kinases which regulate 
NF-KB activation. Although further studies are needed to in-
vestigate the precise mechanism of LPS-stimulated NF -KB acti-
vation, it should be noted that NF-KB activation is sensitive to 
a low concentration of herbimycin A in C6 glioma cells. 
4.2. IFN-y stimulates JAK2 and slightly stimulates JAKl, hut 
not Tyk2 
It has been shown that IFN-y stimulates the receptor-associ-
ated tyrosine protein kinases JAK I and JAK2 in several cell 
types [19]. In the present study, we demonstrated that IFN-y-
induced tyrosine-phosphorylation of JAK2 was more stimu-
lated than that of JAKI in C6 glioma cells. Moreover, LPS 
exerted no effect on phosphorylation of these kinases (unpub-
lished data). JAK2 is known to cause tyrosine-phosphorylation 
of the substrate STATIa (p91) [23]. Tyrosine-phosphorylated 
STATIa can translocate to the nucleus from the cytosol and 
acts as a transcriptional factor [23]. Indeed, recognition sites for 
IFN-y as well as NF-KB are present in the promoter of mouse 
iNOS [8]. Hence, inhibition of JAK2 by herbimycin A may 
bring about a lack of the transcription factor, STATla, which 
is needed for iNOS mRNA expression. We confirmed that 
IFN-y stimulated tyrosine-phosphorylation of both JAK2 and 
STATl:x in rat primary glial cells (unpublished data). 
4.3. Conclusion 
The results presented here show that herbimycin A inhibits 
LPS- plus IFN-y-stimulated induction of NOS in C6 glioma 
cells. Feinstein et al. [9) reported previously that LPS or the 
T Nisluya et al I FEES Leiters 371 (1995) 333-336 
cytokines IL-IJ3, IFN-y, or TNF-a alone did not induce NOS 
expression, but combination of LPS and each 'cytokine signifi-
cantly stimulated the induction of NOS at the protein level in 
C6 glioma cells [8]. The signal transduction system involved in 
iNOS induction has not been investigated previously in primary 
cultured glial cells or astrocytes, C6 glioma cells. Our findings 
suggest the possibility that dual signal pathways are required 
to induce NOS in C6 glioma cells; i.e. LPS-stimulated NF-KB 
activation and IFN-y-stimulated tyrosine-phosphorylation of 
JAK2 related to activation of the transcription factor STATla. 
The intracellular mechanism of iN OS induction by LPS plus 
IFN-y in C6 glioma cells remains for further investigation. 
Acknowledgments' We thank Dr. H. Esuml for the gift of the plasmid 
PTZ 18U. This study was supported by Special Coordination Funds 
for Promotmg Science and Technology from the Science and Technol-
ogy Agency, and by a Grant-m-Ald from the Millistry of EducatIOn, 
Science and Culture, in Japan. 
References 
[I] Moncada, S., Palmar, R.M. and Higgs, E.A. (1991) Pharmacol. 
Rev. 43, 109-142. 
[2] Nathan, C. (1992) FASEB J. 6, 3051-3064. 
[3] Dawson, T.M., Dawson, Y.L. and Snyder, S.H. (1992) Ann. Neu-
rol. 32, 297-311. 
[4] Galea, E., Feinstein, D.L. and Reis. DJ. (1992) Proc Natl. Acad. 
SCI. USA 89. 10945-10949. 
[5] Weisz. A .. Oguchl, S., Cicatiello, L. and Esumi. H. (1994) J. BioI. 
Chern. 269, 8324-8333. 
[6] Nomura, Y. and Kitamura. Y. (1993) Neuroscl. Res. 18. 103-107. 
[7] Xie. Q.-w., Kashiwabara. Y. and Nathan. C (1994) J. BioI. Chern. 
269, 4705-4708 
[8] Xle, Q.-W .. Whisnant. R. and Nathan, C (1993)1. Exp. Med. 177, 
1779-1784. 
[9] Femstem. D.L.. Galea. E .. Cermak. J .. Chugh, P., Lyandvert. L. 
and Reis, DJ. (1994) J. Neurochem. 62, 811-814. 
[10] Akiyama. T.. Ishida. J .. Nakagawa. S .. Ogaware. H., Watanabe. 
S . Itoh, N .. Shibuy. M. and Fukaml. Y. (1987) J. BioI Chern. 262, 
5592-5595 
[II] Uehara. Y. and Fukazawa. H. (1991) Methods Enzymol. 201, 
370-379. 
[12] Adachi. H., Iida. S .. Oguchi, S .. Ohshlma. H .. Suzuki. H., 
Nagasaki. K., Kawasaki. H., Suglmura, T. and Esumi. H. (1993) 
Eur. J. BlOchem .. 217. 37-43 
[13] DaVIS. L.G .. Kuehl, W.H and Battey, J.F (1993) in: BaSIC Meth-
ods m Molecular Biology. 2nd edn .. pp. 322-325 
[14] Kunbayashl, K. Hikata. M .. Hiraoka. O. Miyamoto, C and 
Furuichl, Y. (19X8) NucleiC ACid Research Symposium Series No. 
19.61-64 
[15] Schreiber. E .. Matthias, P .. Muller, M.M. and Schattner. W. 
(1989) NucleiC Acids Res. 17.6419. 
[16] Schreck. R., Meier, B.. Mannel. D.N., Droge. W. and Baeuerle, 
P.A (1992)J. Exp. Med. 175.1181-1194. 
[17] LIOU, H-C. Sha. W.C . Scott. M.L. and Baltimore, D. (1994) Mol. 
Cell. BioI. 14. 5349-5359. 
[18] HazlOt. A., Chen, S .. Ferrero, E., Low. M.G .. Silber. R. and 
Goyert. S.M. (1988) J. Immunol. 141, 547-552. 
[19] Shual. K .. ZiemieckI. A .. Wilks, A.F.. Harpur, A.G., Sadowski. 
H.B.. Gilman, M.Z. and Darnell, J.E. (1993) Nature 366.580--583. 
[20] Stefanova. I., Corcoran. M.L., Horak, E.M., Wahl. L.M., Bolan, 
J.B. and Horak. I.D. (1993) J. BioI. Chern 268,20725-20728. 
[21] Delude. R L. Fenton. M J., Savedra, R., Perera, P.-Y., Vogel, 
S N .. Thlennger. R. and Golenbock, D.T. (1994) J. BIOI. Chern. 
269. 22253-22260. 
[22] Anderson. M.T.. Staal. F.J.T.. Gltler. C, Herzenberg, L.A. and 
Herzenberg. L.A. (1994) Proc. Natl. Acad. SCI. USA 91, 11527-
11531. 
[23] Igarashi. K .. Garotta, G., Ozmen. L.. Ziemiecki, A .. Wilks, A.F .. 
Harpur. A.G., Larner. A C and Finbloom, D.S. (1994) J. BioI. 
Chern 269. 14333-14336. 
